Detalles de la búsqueda
1.
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Lancet
; 388(10063): 2997-3005, 2016 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27908454
2.
Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
J Clin Oncol
; 36(10): 968-974, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29373094
3.
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase.
Breast Cancer (Dove Med Press)
; 6: 179-89, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25473312
Resultados
1 -
3
de 3
1
Próxima >
>>